Arnaud Bonnefoy Selected Research

Arnaud Bonnefoy Research Topics

Disease

9	Thrombosis (Thrombus) 08/2015 - 03/2003
4	Hemophilia A (Haemophilia) 01/2022 - 11/2018
4	Inflammation (Inflammations) 10/2020 - 11/2002
3	Glomerulonephritis 05/2022 - 06/2019
3	Proteinuria 05/2022 - 06/2019
3	Hemorrhage 12/2021 - 07/2003
2	Vasculitis (Vasculitides) 05/2022 - 10/2020
2	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2022 - 10/2020
2	IGA Glomerulonephritis (IGA Nephropathy) 05/2022 - 10/2020
2	Lupus Nephritis 05/2022 - 10/2020
2	Hemophilia B (Haemophilia B) 11/2021 - 07/2021
2	Wounds and Injuries (Trauma) 01/2021 - 02/2007
2	Segmental glomerulosclerosis 10/2020 - 06/2019
2	Fibrosis (Cirrhosis) 10/2020 - 06/2019
2	Hereditary Angioedemas 01/2020 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 08/2015
2	Thrombotic Thrombocytopenic Purpura 01/2018 - 02/2006
2	Neoplasms (Cancer) 01/2008 - 01/2007
2	Neoplasm Metastasis (Metastasis) 01/2008 - 01/2007
2	Atherosclerosis 01/2005 - 03/2003
1	Sclerosis 05/2022
1	Immune System Diseases (Immune Disorders) 12/2021
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2021
1	Angioedema 01/2020
1	Edema (Dropsy) 01/2020
1	Acquired angioedema 01/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 06/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	acquired Thrombotic thrombocytopenic purpura 01/2018
1	Atypical Hemolytic Uremic Syndrome 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Anemia 01/2016
1	Febrile Neutropenia 08/2015
1	Infections 08/2015
1	Myocardial Infarction 07/2012
1	ST Elevation Myocardial Infarction 07/2012
1	Ischemia 07/2012
1	Primary Myelofibrosis (Myelosclerosis) 01/2011

Drug/Important Bio-Agent (IBA)

5	Complement System Proteins (Complement)IBA 05/2022 - 07/2012
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2012
4	von Willebrand FactorIBA 11/2018 - 07/2003
3	AutoantibodiesIBA 05/2022 - 01/2018
3	AntibodiesIBA 01/2022 - 02/2006
3	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 03/2019
3	Fibrinogen (Factor I)FDA Link 01/2021 - 08/2015
3	Thrombospondin 1IBA 01/2011 - 02/2006
3	CollagenIBA 11/2007 - 05/2003
3	P-SelectinIBA 01/2005 - 11/2002
2	Immunoglobulin A (IgA)IBA 12/2021 - 06/2019
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2021 - 07/2021
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2020 - 06/2019
2	BradykininIBA 01/2020 - 01/2018
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 06/2019 - 07/2012
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2019 - 08/2015
2	AntithrombinsIBA 01/2019 - 08/2015
2	Asparaginase (Elspar)FDA Link 01/2019 - 08/2015
2	thiamine triphosphorate (TTP)IBA 01/2018 - 02/2006
2	Peptides (Polypeptides)IBA 01/2017 - 11/2002
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 07/2012
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2006 - 05/2003
1	LectinsIBA 05/2022
1	Immunoglobulin M (IgM)IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	Immunoglobulin IsotypesIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Recombinant Fusion ProteinsIBA 11/2021
1	IntegrinsIBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2020
1	CreatinineIBA 10/2020
1	Factor XII (Hageman Factor)IBA 01/2020
1	PlasminogenIBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Serine Proteases (Serine Protease)IBA 06/2019
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 06/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2019
1	Neutralizing AntibodiesIBA 03/2019
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 11/2018
1	ABO Blood-Group SystemIBA 11/2018
1	eculizumab FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	KininsIBA 01/2018
1	Fibrinolysin FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	pexelizumabIBA 07/2012
1	AnaphylatoxinsIBA 04/2011
1	Anaphylatoxin C5a ReceptorIBA 04/2011
1	Thrombopoietin (c-mpl Ligand)IBA 01/2011
1	CytokinesIBA 01/2011
1	Integrin beta3 (GPIIIa)IBA 05/2008
1	VitronectinIBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2008 - 01/2007
2	Intravenous Injections 01/2006 - 05/2003
1	Perioperative Care 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Percutaneous Coronary Intervention 07/2012